Amorcyte is a clinical stage Cardiovascular Disease Cell Therapy Company Read more…
1st Patient Enrolled in HER2+ bladder carcinoma study; the 2nd Active Cellular Immunotherapy Product Candidate, DN24-02
P1 Study of MultiStem(R) targeting risk for Graft Versus Host Disease Read more…
Good morning! Here’s what you … might need to know to start the day… Read more…
End of Day, Cause and Effect … Read more…
Venture capital deal volume in the healthcare industry continued its downward trend in Q3. Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
3 types of grants will fund basic, translational and clinical stem cell research Read more…
Good morning! Here’s what you … might need to know to start the day… Read more…
End of Day, Cause and Effect … Read more…
Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.